# Standard Triple Therapy vs Sequential Therapy in Treatment of H Pylori Infection

> **NCT01723059** · NA · UNKNOWN · sponsor: **Dallas VA Medical Center** · enrollment: 184 (estimated)

## Conditions studied

- Helicobacter Infection

## Interventions

- **DRUG:** Standard Triple Therapy
- **DRUG:** Sequential Therapy

## Key facts

- **NCT ID:** NCT01723059
- **Lead sponsor:** Dallas VA Medical Center
- **Sponsor class:** FED
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-02
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 184 (ESTIMATED)
- **Last updated:** 2012-11-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01723059

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01723059, "Standard Triple Therapy vs Sequential Therapy in Treatment of H Pylori Infection". Retrieved via AI Analytics 2026-09-22 from https://api.ai-analytics.org/clinical/NCT01723059. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*